Untitled

Heinemann, L.; Potthoff, Peter; Schneider, H. P. G.

doi:10.1186/1477-7525-1-28

Cited by 326 publications

(146 citation statements)

References 6 publications

Supporting

Mentioning

121

Contrasting

Unclassified

Order By: Relevance

“…At each follow-up (0 months - which is the last month of treatment -, 6-12 months, 24 months and 36 months after discontinuation), the prevalence and intensity of menopausal symptoms were scored based on the Menopause Rating Scale [26]. This questionnaire was also used to score menopausal symptoms prior to initiating LT-HRT.…”

Section: Methodsmentioning

confidence: 99%

Menopausal Symptoms after the Discontinuation of Long-Term Hormone Replacement Therapy in Women under 60: A 3-Year Follow-Up

Perrone¹,

Capri

Gabriela

et al. 2013

Gynecol Obstet Invest

View full text Add to dashboard Cite

Background: Prescriptions for hormone replacement therapy (HRT) declined following the publication of the Women's Health Initiative study. The number of women who experience recurrence of menopausal symptoms after discontinuation of long-term HRT (LT-HRT), the length of time these symptoms last and the preferred alternative treatments remain unknown. Methods: This prospective 3-year follow-up study analyses the prevalence and intensity of menopausal symptoms that occur in young postmenopausal women who discontinued LT-HRT. Symptoms were evaluated using the Menopause Rating Scale. Results: Women (254) who discontinued LT-HRT (mean use: 6.9 ± 2.3 years) were recruited. Mean age at menopause was 48.1 ± 3.4 years. Mean age at discontinuation was 56.8 ± 3.7 years. 23% of the women were lost to follow-up. Of the remaining 196 women, 93% experienced a recurrence of menopausal symptoms within the first year, 25% resumed low-dose HRT, 62% used vaginal estrogens, 54% used phytoestrogens, and 2% used alternative therapies. A decrease in symptom prevalence and intensity was observed during the 3-year follow-up. Conclusions: Symptoms re-appeared in a significant proportion of patients within the first year after discontinuation of LT-HRT. However, after 3 years, the majority of these women were asymptomatic. Patients who discontinue LT-HRT may require a more detailed follow-up immediately after the discontinuation of treatment.

show abstract

Section: Methodsmentioning

confidence: 99%

Menopausal Symptoms after the Discontinuation of Long-Term Hormone Replacement Therapy in Women under 60: A 3-Year Follow-Up

Perrone¹,

Capri

Gabriela

et al. 2013

Gynecol Obstet Invest

View full text Add to dashboard Cite

show abstract

“…Various tools or instruments have been designed to measure and assess symptoms during the menopausal transition, among them is Menopause Rating Scale (MRS) which is designed to assess menopause specific health related quantity of life (QoL) to measure the severity of age/menopause-related complaints by rating a profile of symptoms [15,16]. …”

Section: Introductionmentioning

confidence: 99%

Assessment of menopausal symptoms using modified Menopause Rating Scale (MRS) among middle age women in Kuching, Sarawak, Malaysia

2010

View full text Add to dashboard Cite

BackgroundMenopausal symptoms can be assessed by several tools, and can be influenced by various socio-demographic factors.ObjectivesTo determine the commonly reported menopausal symptoms among Sarawakian women using a modified Menopause Rating Scale (MRS).MethodsBy using modified MRS questionnaire, 356 Sarawakian women aged 40-65 years were interview to document of 11 symptoms (divided into somatic, psychological and urogenital domain) commonly associated with menopause.ResultsThe mean age of menopause was 51.3 years (range 47 - 56 years). The most prevalent symptoms reported were joint and muscular discomfort (80.1%); physical and mental exhaustion (67.1%); and sleeping problems (52.2%). Followed by symptoms of hot flushes and sweating (41.6%); irritability (37.9%); dryness of vagina (37.9%); anxiety (36.5%); depressive mood (32.6%). Other complaints noted were sexual problem (30.9%); bladder problem (13.8%) and heart discomfort (18.3%). Perimenopausal women (n = 141) experienced higher prevalence of somatic and psychological symptoms compared to premenopausal (n = 82) and postmenopausal (n = 133) women. However urogenital symptoms mostly occur in the postmenopausal group of women.ConclusionsThe prevalence of menopausal symptoms using modified MRS in this study correspond to other studies on Asian women however the prevalence of classical menopausal symptoms of hot flushes, sweating was lower compared to studies on Caucasian women.

show abstract

“…Improvement in other menopausal symptoms derived from overall numerical results by using different measurements e.g. Kupperman Index (KI) (Kupperman 1959); Menopause-Specific Quality of Life Questionnaire (MENQOL) (Hilditch 1996); Greene Climateric Scale (GCS) (Greene 1976); Women’s Health Questionnaire (WHQ) (Hunter 1992); Menopause Rating Scale (MRS) (Hauser 1994; Heinemann 2003; Potthoff 2000); and Hot Flash Related Daily Interference Scale (HFRDI) (Carpenter 2001). Chinese studies tended to use different measurements; measuring a successful rate for menopausal symptoms (Ministry of Health of PRC 1995).…”

Section: Methodsmentioning

confidence: 99%